Peptide Stack

CJC-1295 + Ipamorelin

CJC/IPA · Mod GRF + ipamorelin · CJC-1295 no-DAC + ipamorelin

Classic GHRH + GHRP research stack: CJC-1295 without DAC (MOD-GRF 1-29) plus ipamorelin. We have the singles, a sermorelin + ipamorelin leaf, and a blog — this is the named CJC/ipa blend SKU. Use no-DAC CJC, not the weekly DAC form, if the goal is a bedtime pulse.

Not FDA-approved — research chemicalWADA (S2) — prohibited in sport at all times

Reviewed by CalcMyPeptide Editorial Team

·Last updated: April 2026·Evidence: Low·1 peer-reviewed citation

Typical research dose

100-200 mcg CJC no-DAC + 200-300 mcg ipamorelin per injection

Frequency

1-2× daily (empty stomach, often before bed)

Half-life

~30 min + ~2 h

Common vials

5 mg / 10 mg

CAS

N/A (blend)

Molecular weight

Blend

Dose it

10 mg + 2 mL BAC water → 5 mg/mL · 300 mcg ≈ 6 units (U-100)

Open in calculator

Mechanism of Action

CJC-1295 without DAC (MOD-GRF 1-29) plus ipamorelin is the standard pulse stack: GHRH-receptor amplitude plus GHS-R1a initiation. Use no-DAC CJC. DAC CJC is a multi-day GH bleed and is the wrong partner for a bedtime pulse.

We already documented this in the ipamorelin + CJC-1295 blog. This leaf is the library SKU.

Source: See CJC-1295 no-DAC and ipamorelin entries; blog: /blog/ipamorelin-cjc-1295-stack

Dosing Protocol

Typical Dose	100-200 mcg CJC no-DAC + 200-300 mcg ipamorelin per injection
Frequency	1-2× daily (empty stomach, often before bed)
Half-Life	~30 min (CJC no-DAC) / ~2 hours (ipamorelin)
Common Vial Sizes	5 mg, 10 mg

Dosing Protocols

Typical pulse protocol

Dose

CJC no-DAC 100–200 mcg + ipamorelin 200–300 mcg

Frequency

1–2× daily empty stomach

Note: Often 30–60 min before bed. Pre-mixed vial ratios vary — calculate from the actual mg of each.

Administration

Route

Subcutaneous

Timing

Empty stomach. Bedtime common.

Fasting Required?

Yes — inject on an empty stomach

Expected Timeline

Acute

GH pulse over a few hours if no-DAC CJC is used.

Weeks

IGF-1 change is protocol- and baseline-dependent. Not a labeled outcome for the blend.

Who Is It For?

GH pulse stack

Moderate

Each peptide has some human secretagogue data. The blend is compounding practice.

Reconstitution Example

Vial

10 mg

Diluent

2 mL

Concentration

5 mg/mL

Per Unit (100u syringe)

50 mcg

Dose of 300 mcg = 6 units on a 100-unit insulin syringe

🧮 Calculate Your Exact CJC-1295 + Ipamorelin Dose →

Safety & Considerations

Research stack. Fasting glucose, edema, tingling. WADA S2. Do not combine with exogenous GH without a clinician.

Regulatory & Legal Status

FDA Status (US)

Research Only

WADA Status (2026)

Prohibited (S2)

Competitive athletes subject to anti-doping controls should not use CJC-1295 + Ipamorelin.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

CJC-1295 + Ipamorelin vs. Sermorelin + Ipamorelin

Attribute	CJC-1295 + Ipamorelin	Sermorelin + Ipamorelin
GHRH analog	CJC no-DAC / MOD-GRF (~30 min)	Sermorelin / GHRH 1-29 (~10–20 min)
GHRP	Ipamorelin	Ipamorelin
Pulse vs bleed	Use no-DAC, not DAC CJC	Always a pulse (no DAC form)
FDA	Neither approved as a combo	Sermorelin formerly approved (Geref); combo is compounded